101 – 110 of 140
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations : effect of a prospective intervention in primary bladder cancer patients
(
- Contribution to journal › Article
-
Mark
Erdafitinib in Urothelial Carcinoma
(
- Contribution to journal › Letter
-
Mark
Who should record surgical complications? Results from a third-party assessment of complications after radical cystectomy
(
- Contribution to journal › Article
-
Mark
Molecular pathology of the luminal class of urothelial tumors
(
- Contribution to journal › Article
-
Mark
Serum chemerin levels are negatively associated with male fertility and reproductive hormones
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Molecular subtypes applied to a population-based modern cystectomy series do not predict cancer-specific survival
(
- Contribution to journal › Article
-
Mark
Intravesical therapy - BCG and beyond
(
- Contribution to journal › Article
-
Mark
Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care : a nationwide population-based study
(
- Contribution to journal › Article
- 2018
-
Mark
Port-site Metastases After Robot-assisted Radical Cystectomy : Is There a Publication Bias?
(
- Contribution to journal › Letter
-
Mark
Molecular subtype profiling of urothelial carcinoma using a subtype-specific immunohistochemistry panel
(
- Chapter in Book/Report/Conference proceeding › Book chapter